Innovations in global health: What has been accomplished, what is on the horizon and where are more investments needed
2018
- 53Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage53
- Abstract Views53
Abstract Description
The introduction of vaccines ranks as one of the greatest healthcare achievements in modern history. Through the global efforts of the vaccine community, small pox has been eradicated worldwide, as has one of three wild type strains of polio. Other infectious diseases such as measles have been eliminated from large regions of the world. All of these advances have contributed to increases in health around the globe. However, continued success will depend on continued innovation. Recent technical advances include the introduction into clinical studies of new vaccine vectors such as mRNA, new methods to administer vaccine such as microneedle array patches, improvements in the thermostabilization of vaccines and the use of process intensification, continuous processing and modular facility design to improve vaccine manufacturing. Still, significant efforts are needed to see each of these advances through conceptualization and pilot studies into widespread adoption and implementation. In addition, additional investments are needed in novel designs for filling/packaging of vaccines, methods to reduce the number of injections each child must receive and improvements in the speed and reliability of vaccine manufacturing and release. The speaker will touch upon each of these topics during the presentation.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know